Kaylyn M. Bell
About Kaylyn M. Bell
Kaylyn M. Bell is a Scientist at Bristol Myers Squibb in Brisbane, California, specializing in developing targeted therapeutics for cardiovascular disease.
Current Position at Bristol Myers Squibb
Kaylyn M. Bell is currently employed as a Scientist at Bristol Myers Squibb. Her work is based in Brisbane, California, United States. She focuses on developing targeted therapeutics for cardiovascular disease. This position leverages her expertise in ex vivo muscle fiber mechanical analysis, making significant contributions to the field.
Previous Role at MyoKardia
Kaylyn worked at MyoKardia as a Postdoctoral Researcher from 2019 to 2020. During her one-year tenure in the San Francisco Bay Area, she focused on developing advanced treatment methodologies for cardiovascular conditions. This role involved collaborative research efforts to drive innovation in medical therapeutics.
Educational Background at Rensselaer Polytechnic Institute
Kaylyn M. Bell studied at Rensselaer Polytechnic Institute, where she earned both her BS in Biophysics and a PhD in Biochemistry and Biophysics through an Accelerated BS/PhD program. Her educational journey at Rensselaer spanned from 2011 to 2018. During her time there, she studied the muscle mechanics of human cardiac and skeletal muscle diseases under the guidance of Douglas Swank.
Research and Expertise in Muscle Mechanics
Kaylyn's research focuses on the muscle mechanics of human cardiac and skeletal muscle diseases, an area she explored extensively under Douglas Swank at Rensselaer Polytechnic Institute. She has developed a strong expertise in ex vivo muscle fiber mechanical analysis, contributing valuable insights into the mechanics of muscular diseases.